Lv6
2150 积分 2024-11-03 加入
Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma
10天前
已完结
Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: A China Lymphoma Collaborative Group study
10天前
已完结
Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma
10天前
已完结
The Treatment of Marginal Zone Lymphoma
3个月前
已完结
Multifocal soft tissue Langerhans’ cell histiocytosis treated with PET-CT based conformal radiotherapy
3个月前
已完结
Radiation dose and fraction in immunotherapy: one-size regimen does not fit all settings, so how does one choose?
3个月前
已完结
High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: Results of a phase II trial
3个月前
已完结
Low-Dose Radiotherapy Reverses Tumor Immune Desertification and Resistance to Immunotherapy
3个月前
已完结
Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial
3个月前
已完结
Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial
3个月前
已完结
皖公网安备34019202002308
